Cargando…

Neurogenic Erectile Dysfunction. Where Do We Stand?

Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculo...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Charalampos, Konstantinidis, Charalampos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825654/
https://www.ncbi.nlm.nih.gov/pubmed/33430218
http://dx.doi.org/10.3390/medicines8010003
_version_ 1783640357078040576
author Thomas, Charalampos
Konstantinidis, Charalampos
author_facet Thomas, Charalampos
Konstantinidis, Charalampos
author_sort Thomas, Charalampos
collection PubMed
description Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or psychogenic. Neurogenic ED consists of a large cohort of ED, accounting for about 10% to 19% of all cases. Its diversity does not allow an in-depth clarification of all the underlying mechanisms nor a “one size fits all” therapeutical approach. In this review, we focus on neurogenic causes of ED, trying to elucidate the mechanisms that lie beneath it and how we manage these patients.
format Online
Article
Text
id pubmed-7825654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78256542021-01-24 Neurogenic Erectile Dysfunction. Where Do We Stand? Thomas, Charalampos Konstantinidis, Charalampos Medicines (Basel) Review Erectile Dysfunction (ED) is the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual performance, causing tremendous effects on both patients and their partners. The pathophysiology of ED remains a labyrinth. The underlying mechanisms of ED may be vasculogenic, neurogenic, anatomical, hormonal, drug-induced and/or psychogenic. Neurogenic ED consists of a large cohort of ED, accounting for about 10% to 19% of all cases. Its diversity does not allow an in-depth clarification of all the underlying mechanisms nor a “one size fits all” therapeutical approach. In this review, we focus on neurogenic causes of ED, trying to elucidate the mechanisms that lie beneath it and how we manage these patients. MDPI 2021-01-07 /pmc/articles/PMC7825654/ /pubmed/33430218 http://dx.doi.org/10.3390/medicines8010003 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Thomas, Charalampos
Konstantinidis, Charalampos
Neurogenic Erectile Dysfunction. Where Do We Stand?
title Neurogenic Erectile Dysfunction. Where Do We Stand?
title_full Neurogenic Erectile Dysfunction. Where Do We Stand?
title_fullStr Neurogenic Erectile Dysfunction. Where Do We Stand?
title_full_unstemmed Neurogenic Erectile Dysfunction. Where Do We Stand?
title_short Neurogenic Erectile Dysfunction. Where Do We Stand?
title_sort neurogenic erectile dysfunction. where do we stand?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825654/
https://www.ncbi.nlm.nih.gov/pubmed/33430218
http://dx.doi.org/10.3390/medicines8010003
work_keys_str_mv AT thomascharalampos neurogenicerectiledysfunctionwheredowestand
AT konstantinidischaralampos neurogenicerectiledysfunctionwheredowestand